Free Trial

4,310 Shares in Astera Labs, Inc. $ALAB Acquired by Praxis Investment Management Inc.

Astera Labs logo with Computer and Technology background

Key Points

  • Praxis Investment Management Inc. acquired 4,310 shares of Astera Labs, valued at approximately $390,000, marking a new investment position in the company.
  • Astera Labs recently reported a 149.5% year-over-year revenue increase with earnings per share (EPS) of $0.44 for the last quarter, exceeding analysts' estimates.
  • Recent analyst ratings for Astera Labs include a "neutral" rating from Bank of America and a "hold" rating from TD Cowen, with an average target price set at $162.06.
  • MarketBeat previews top five stocks to own in November.

Praxis Investment Management Inc. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,310 shares of the company's stock, valued at approximately $390,000.

Other large investors have also recently added to or reduced their stakes in the company. Fred Alger Management LLC boosted its holdings in Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after buying an additional 179,638 shares in the last quarter. Hoey Investments Inc. boosted its holdings in Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock worth $553,000 after buying an additional 1,121 shares in the last quarter. Wealth Effects LLC bought a new stake in Astera Labs during the second quarter worth approximately $242,000. Maryland State Retirement & Pension System boosted its holdings in Astera Labs by 37.7% during the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company's stock worth $629,000 after buying an additional 1,906 shares in the last quarter. Finally, Realta Investment Advisors bought a new stake in Astera Labs during the second quarter worth approximately $214,000. 60.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Bank of America began coverage on shares of Astera Labs in a report on Friday, October 3rd. They set a "neutral" rating and a $230.00 target price for the company. TD Cowen began coverage on shares of Astera Labs in a research note on Wednesday, October 1st. They issued a "hold" rating and a $200.00 price objective for the company. Zacks Research lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 6th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. Finally, Jefferies Financial Group raised their price objective on shares of Astera Labs from $95.00 to $130.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Fifteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat.com, Astera Labs currently has an average rating of "Moderate Buy" and an average target price of $162.06.

View Our Latest Stock Report on ALAB

Astera Labs Stock Down 2.3%

Shares of NASDAQ:ALAB opened at $159.80 on Friday. The firm has a fifty day moving average of $199.68 and a two-hundred day moving average of $128.30. The firm has a market capitalization of $26.56 billion, a P/E ratio of 285.36, a price-to-earnings-growth ratio of 3.98 and a beta of 1.43. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company's revenue for the quarter was up 149.5% on a year-over-year basis. During the same quarter last year, the business posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 91,441 shares of the firm's stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the transaction, the chief operating officer owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. This trade represents a 4.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jack R. Lazar sold 22,500 shares of the firm's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the transaction, the director owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,182,514 shares of company stock worth $202,298,671. 12.50% of the stock is currently owned by company insiders.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.